New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?

Weekly cisplatin shows similar burden of acute treatment side effects as every 3-week schedule for patients with p16-negative head and neck cancer on NRG oncology trial

NRG Oncology trial results show no survival benefit with the use of proton therapy for patients with advanced hepatocellular carcinoma

Up to one in three people with type 2 diabetes develop serious heart or kidney disease or die within five years of diagnosis, study of 1.6 million patients suggests